Zen Faulkes at NeuroDojo says that "genius is overrated" in science. He says that in science, as in art, the public harbors the assumption that "it’s about creativity, and waiting for the muse, when often the reality is that 90 percent of the job is just showing up and doing the work." Faulkes continues to say that nearly every scientific project "has an extraordinary amount of grunt work behind it," and that he wishes that aspect of the profession was more widely acknowledged.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.